Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.08.28.747827

Sex-specific regulation of macrophage function determines outcome to acute bacterial infection

Abstract

Sex differences in infection outcome are widespread across sexually reproducing animals. The immune mechanisms generating these differences remain incompletely understood, in part because it is challenging to decompose systemic effects from cell-intrinsic regulation in mammalian model systems and clinical data. Sex-biased infection outcomes are observed in taxa lacking adaptive immunity, suggesting that innate immune cells, such as macrophages, have the potential to drive dimorphisms. It is largely unknown whether macrophage-intrinsic sex identity is causal for infection susceptibility, or for sex differences in other, homeostatic functions. Here, we address this question using Drosophila melanogaster, an in vivo model of innate immunity where sex is established, and can be manipulated, cell-autonomously. We show that during infection by the bacterium Staphylococcus aureus, adult male flies succumb faster than females, with more rapid early bacterial proliferation. Hemocyte ablation reveals that survival is hemocyte-dependent in both sexes, and flow cytometry indicates a higher fraction of actively phagocytic hemocytes in females. Critically, genetically feminizing male hemocytes abolishes the dimorphism in survival and bacterial burden in S. aureus infection, bringing feminized males to the equivalent load and mortality risk as females. Transcriptomic analysis of whole carcasses shows strongly sex-biased responses during S. aureus infection, whereas hemocyte-specific RNA-sequencing reveals minimal sex differences in induced responses but substantial, sustained baseline transcriptomic divergence, including female-biased expression of bactericidal mechanisms linked to ROS generation and lysozyme production. Together, these findings demonstrate that the sex identity of innate immune cells is sufficient to shape infection outcome.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Belmonte, R. L., Aleksandrowicz, J., Pumpe, C., Mika, P., Corbally, M.-K., Duneau, D. F., Regan, J. C.. 2026-09-03. Sex-specific regulation of macrophage function determines outcome to acute bacterial infection. https://doi.org/10.64898/2026.08.28.747827

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗